arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 5/2009 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    NEW ON THE MARKET

    Agomelatine (VALDOXAN) for major depressive disorder

    Low dose orlistat (ALLI) now OTC

    THERAPY FROM A CRITICAL VIEWPOINT

    Clopidogrel and aspirin in patients with atrial fibrillation

    Valsartan (DIOVAN): no protection against atrial fibrillation

    Strict control of blood glucose in critical ill patients?

    a-t READER'S QUESTIONS AND COMMENTS

    For how long adjuvant tamoxifen (e.g. NOLVADEX) in breast cancer

    IN BRIEF

    Pharmaceutical quality of all tested gabapentin products okay

    Calcium dobesilate without benefit in diabetic retinopathy

    Merck & Co: dubious marketing strategies

    CURRENT ADR NETWORK REPORT

    Are disposal boxes for syringes sufficient safe?

    Erratum: non vertebral fractures due to ibandronate (e.g. BONVIVA)

    SIDE EFFECTS

    Sertindole (SERDOLECT): Cardiotoxicity confirmed
    free

    Strontium ranelate (PROTELOS) causes alopecia

    Gastrointestinal perforation due to erlotinib (TARCEVA)

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles